BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 25, 2025
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Coronavirus vaccine/therapeutics illustration

Taxpayer-enabled COVID-19 vaccines will cost less, but distribution system requires another at-risk investment

July 2, 2020
By Mark McCarty
The question of prices for a COVID-19 vaccine have raged in recent days. Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA), told members of a Senate committee that vaccines developed with the help of taxpayer funding will come with an appropriate reduction in price. However, CDC Director Robert Redfield emphasized that the cold-chain distribution system for those products requires the same kind of at-risk investment that is used for vaccine development.
Read More
Product image

Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly

July 2, 2020
By Stacy Lawrence
Startup Nanodiagnostics Inc. has been working for years toward a panel of point-of-care tests, helmed by one for traumatic brain injury.
Read More

Regulatory actions for July 2, 2020

July 2, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Life Whisperer, Phosphorus, Sagico, Spinal Elements.
Read More
Novel coronavirus SARS-CoV-2

University of Sao Paulo moves forward with ‘second-generation’ SARS-CoV-2 vaccine

July 1, 2020
By Sergio Held
CAJICA, Colombia – Aided by federal funds from the Brazilian government, the University of Sao Paulo is moving forward with developing a precision SARS-CoV-2 vaccine that is about to start preclinical trials.
Read More
COVID-19 vaccine vials behind U.S. capitol building

FDA posts guidance for COVID-19 vaccines as Hahn assures FDA will cut no corners

June 30, 2020
By Mark McCarty
The push for a vaccine for the COVID-19 pandemic may have no parallel in pharmaceutical history, and FDA commissioner Stephen Hahn vowed in a Senate hearing that the agency will rely on the agency’s traditional standards for scientific evidence in premarket reviews of those vaccines.
Read More

Regulatory actions for June 30, 2020

June 30, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerus, Ancora Heart, Corelink, Endra Life Sciences, Illuminoss Medical, Kardium, Livsmed, Qure.ai, Seegene.
Read More

Other news to note for June 30, 2020

June 30, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Activ Surgical, Alberta Health Services, Ambu, Ascom, Biocorp, Blueprint Medicines, Ci Security, Coeus Consulting, C-Rad, Cylera, Dermtech, Endbraincancer Initiative, Flir Systems, Forest Devices, Fuel Medical Group, Gt Medical Technologies, Helferapp, Humana, Innominds Software, Ion Beam Applications, Labcorp, Leica Microsystems, Luminex, Medigate, Mindmaze, Novavision, Mirador Global, Mobidiag, Ordr, Oxitone Medical, Plano, Pra Health Sciences, Pressure Biosciences, Proscia, Protxx, Quest Diagnostics, Roche, Royal Philips, Santen Pharmaceutical, Sauber Engineering, Stryker, Trialjectory, Twist Bioscience, Vericel, Vycor Medical, Walmart, Wright Medical Group.
Read More
Cells infected with SARS-CoV-2

COVID-19: Study points to kinases as HIV combo falls flat for SARS-CoV-2

June 29, 2020
By Nuala Moran
LONDON – Scientists investigating the impact of SARS-CoV-19 on protein expression in human cells have shown that infected cells develop virus-laden membrane protrusions, or filopodia, which may explain the rapidity of viral spread through the body.
Read More

Regulatory actions for June 29, 2020

June 29, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beckman Coulter, Boston Scientific, Envoy Medical, Orthofix.
Read More

BioWorld MedTech’s Cardiology Extra for June 29, 2020

June 29, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: COVID-19 an independent risk factor for acute ischemic stroke; New heart valve holds hope for open heart surgery; Company unveils results on therapy to treat cardiovalvular diseases.
Read More
Previous 1 2 … 108 109 110 111 112 113 114 115 116 … 136 137 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing